In November 2024, CStone presented preclinical data for CS2009 at the 39th SITC Annual Meeting. These results show that CS2009 exhibits superior anti-tumor activity compared to potential competitors, ...
As Ms Inyang spoke, she listed different terminal ailments which she claimed could be cured at her facility using alternative medicines, including all kinds of Hepatitis, Cancer and Sickle Cell ...